Daewoong Pharmaceutical Co., Ltd

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022

In its 2023 reporting, Daewoong Pharmaceutical Co., Ltd disclosed greenhouse gas emissions of 33.0K tCO2e/year (Scope 1+2). By scope: Scope 1: 9.7K tCO2e/year; Scope 2: 23.3K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
33.0K tCO2e/year (Scope 1+2)
2023
⚡
Renewable Energy
2.6% of total energy use (2024 Goal)
of total energy
💧
Water Usage
327.8K tons/year
2023
♻️
Waste
1.1K tons/year
2023
⚙️
Energy Use
723.8 TJ/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).9.7K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.23.3K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202333.0K tCO2e/year (Scope 1+2)
202254.9K tCO2eq/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce water consumption by unspecified percentage.
  • Reduce waste volume and increase recycling rates.
  • Install greenhouse gas reduction facilities.

📅 Medium-term

  • Achieve unspecified renewable energy percentage.
  • Establish a dedicated organization for major accident management.

🔭 Long-term

  • Net zero emissions by 2050.

🌱 ESG Focus Areas

Climate ChangeDrug Safety and QualitySustainable Supply Chain ManagementR&D and InnovationHuman Rights and LaborWork-Life BalanceWorkplace Safety and HealthEthical ManagementResponsible Marketing and Customer Satisfaction

⚠️ Challenges & Risks +

  • Increasing demand for eco-friendly drug materials and packaging.
  • Strengthening of environmental laws and regulations.
  • Increased risk of property damage due to extreme weather events.
  • Potential loss of trust and corporate reputation damage due to inadequate climate change response.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards 2021, ISSB, SASB, TCFD, UNGC, UN SDGs
Assurance: Korea Management Registrar (AA1000AS v3)